Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids

E-ISSN： 1873-4286|20|40|6325-6338

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.40, 2014-12, pp. : 6325-6338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging options in the treatment of dyslipidemias: a bright future?

By Florentin Matilda Liberopoulos Evangelos N Mikhailidis Dimitri P Elisaf Moses S

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 2, 2011-06 ,pp. : 247-270

Informa Healthcare

Access to resources Recommend Favorite

The Role of Polyunsaturated Fatty Acids (PUFA) in the Treatment of Dyslipidemias

Current Pharmaceutical Design, Vol. 15, Iss. 36, 2009-12 ,pp. : 4087-4093

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3150-3160

Bentham Science Publishers

Access to resources Recommend Favorite

Medications for the treatment of narcolepsy

By Black Jed Guilleminault Christian

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 239-247

Informa Healthcare

Access to resources Recommend Favorite

Investigational medications in the treatment of alopecia

By Poulos Georgann A Mirmirani Paradi

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 177-184

Informa Healthcare

Access to resources Recommend Favorite